Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer

  1. Makrakis, D.
  2. Talukder, R.
  3. Diamantopoulos, L.N.
  4. Carril-Ajuria, L.
  5. Castellano, D.
  6. De Kouchkovsky, I.
  7. Koshkin, V.S.
  8. Park, J.J.
  9. Alva, A.
  10. Bilen, M.A.
  11. Stewart, T.F.
  12. McKay, R.R.
  13. Santos, V.S.
  14. Agarwal, N.
  15. Jain, J.
  16. Zakharia, Y.
  17. Morales-Barrera, R.
  18. Devitt, M.E.
  19. Grant, M.
  20. Lythgoe, M.P.
  21. Pinato, D.J.
  22. Nelson, A.
  23. Hoimes, C.J.
  24. Shreck, E.
  25. Gartrell, B.A.
  26. Sankin, A.
  27. Tripathi, A.
  28. Zakopoulou, R.
  29. Bamias, A.
  30. Murgic, J.
  31. Fröbe, A.
  32. Rodriguez-Vida, A.
  33. Drakaki, A.
  34. Liu, S.
  35. Kumar, V.
  36. Di Lorenzo, G.
  37. Joshi, M.
  38. Isaacsson-Velho, P.
  39. Buznego, L.A.
  40. Duran, I.
  41. Moses, M.
  42. Barata, P.
  43. Sonpavde, G.
  44. Yu, E.Y.
  45. Wright, J.L.
  46. Grivas, P.
  47. Khaki, A.R.
  48. Erakutsi egile guztiak +
Aldizkaria:
BJU International

ISSN: 1464-410X 1464-4096

Argitalpen urtea: 2022

Alea: 130

Zenbakia: 5

Orrialdeak: 592-603

Mota: Artikulua

DOI: 10.1111/BJU.15603 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak